Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts

Journal of Virology

Volumn 83, Issue 8, 2009, Pages 3684-3695

  Trilling, Mirko ^a   Le, Vu Thuy Khanh ^a   Zimmermann, Albert ^a   Ludwig, Holger ^b   Pfeffer, Klaus ^a   Sutter, Gerd ^b   Smith, Geoffrey L ^c   Hengel, Hartmut ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 1; JANUS KINASE 2; STAT1 PROTEIN; VIRUS DNA; INTERFERON RECEPTOR; IRF1 PROTEIN, HUMAN; IRF1 PROTEIN, MOUSE; JAK2 PROTEIN, MOUSE; STAT1 PROTEIN, MOUSE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA BINDING; ECTROMELIA VIRUS; EMBRYO; FIBROBLAST; GENE DELETION; GENETIC TRANSCRIPTION; HOST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VIROGENESIS; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DNA REPLICATION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY;

ECTROMELIA VIRUS; VACCINIA VIRUS;

ANIMALS; CELLS, CULTURED; DNA REPLICATION; DNA, VIRAL; ECTROMELIA VIRUS; FIBROBLASTS; GENE DELETION; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON-GAMMA; JANUS KINASE 2; MICE; RECEPTORS, INTERFERON; STAT1 TRANSCRIPTION FACTOR; VACCINIA VIRUS; VIRUS REPLICATION;

EID: 64049098144     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02042-08     Document Type: Article

References (83)

1. Ahlers, J. D., I. M. Belyakov, S. Matsui, and J. A. Berzofsky. 2001. Mechanisms of cytokine synergy essential for vaccine protection against viral challenge. Int. Immunol. 13:897-908. (Pubitemid 32685202)
2. Alcamí, A., and G. L. Smith. 1995. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species speci- ficity. J. Virol. 69:4633-4639.
3. Bowie, A., E. Kiss-Toth, J. A. Symons, G. L. Smith, S. K. Dower, and L. A. J. O'Neill. 2000. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 97:10162-10167.
4. Brune, W., H. Hengel, and U. H. Koszinowski. 1999. A mouse model for cytomegalovirus infection, p. 19.7.1-19.7.3. In Current protocols in immunology. John Wiley & Sons, New York, NY.
5. Buller, R. M. L., and G. J. Palumbo. 1991. Poxvirus pathogenesis. Microbiol. Rev. 55:80-122. (Pubitemid 21895147)
6. Chang, H. W., J. C. Watson, and B. L. Jacobs. 1992. The E3l gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 89:4825-4829.
7. Colamonici, O. R., P. Domanski, S. M. Sweitzer, A. Larner, and R. M. L. Buller. 1995. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon-alpha transmembrane signaling. J. Biol. Chem. 270:15974-15978.
8. Darnell, J. E. 1997. STATs and gene regulation. Science 277:1630-1635.
9. Davies, M. V., H.-W. Chang, B. L. Jacobs, and R. J. Kaufman. 1993. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. J. Virol. 67:1688-1692. (Pubitemid 23067681)
10. Degrandi, D., C. Konermann, C. Beuter-Gunia, A. Kresse, J. Wurthner, S. Kurig, S. Beer, and K. Pfeffer. 2007. Extensive characterization of IFNinduced GTPases mGBP1 to mGBP10 involved in host defense. J. Immunol. 179:7729-7740.
11. Der, S. D., A. M. Zhou, R. H. Silverman, and B. R. G. William. 1998. Identification of genes differentially regulated by IFN-alpha, beta, gamma using oligonucleotide microarrays. Eur. Cytokine Netw. 9:374.
12. DiazGuerra, M., C. Rivas, and M. Esteban. 1997. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology 227:220-228.
13. DiPerna, G., J. Stack, A. G. Bowie, A. Boyd, G. Kotwal, Z. N. Zhang, S. Arvikar, E. Latz, K. A. Fitzgerald, and W. L. Marshall. 2004. Poxvirus protein N1L targets the I-kappa B kinase complex, inhibits signaling to NF-kappa B by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappa B and IRF3 signaling by Toll-like receptors. J. Biol. Chem. 279:36570-36578.
14. Drexler, I., K. Heller, B. Wahren, V. Erfle, and G. Sutter. 1998. Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells. J. Gen. Virol. 79:347-352.
15. Dror, N., M. Alter-Koltunoff, A. Azriel, N. Amariglio, J. Jacob-Hirsch, S. Zeligson, A. Morgenstern, T. Tamura, H. Hauser, G. Rechavi, K. Ozato, and B. Z. Levi. 2007. Identification of IRF-8 and IRF-1 target genes in activated macrophages. Mol. Immunol. 44:338-346. (Pubitemid 44308354)
16. Durbin, J. E., R. Hackenmiller, M. C. Simon, and D. E. Levy. 1996. Targeted disruption of the mouse STAT1 results in compromised innate immunity to viral disease. Cell 84:443-450.
17. Erlandsson, L., R. Blumenthal, M. L. Eloranta, H. Engel, G. Alm, S. Weiss, and T. Leanderson. 1998. Interferon-beta is required for interferon-alpha production in mouse fibroblasts. Curr. Biol. 8:223-226. (Pubitemid 28126612)
18. Esteban, D. J., and R. M. L. Buller. 2005. Ectromelia virus: the causative agent of mousepox. J. Gen. Virol. 86:2645-2659.
19. Fenner, F. 1949. Mouse-pox (infectious ectromelia of mice): a review. J. Immunol. 63:341-373.
20. Garcia, M. A., J. Gil, I. Ventoso, S. Guerra, E. Domingo, C. Rivas, and M. Esteban. 2006. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 70:1032-1060.
21. Giavedoni, L. D., L. Jones, M. B. Gardner, H. L. Gibson, C. T. L. Ng, P. J. Barr, and T. Yilma. 1992. Vaccinia virus recombinants expressing chimeric proteins of human immunodeficiency virus and gamma interferon are attenuated for nude mice. Proc. Natl. Acad. Sci. USA 89:3409-3413.
22. Gil, M. P., E. Bohn, A. K. O'Guin, C. V. Ramana, B. Levine, G. R. Stark, H. W. Virgin, and R. D. Schreiber. 2001. Biologic consequences of Stat1-independent IFN signaling. Proc. Natl. Acad. Sci. USA 98:6680-6685.
23. Gubser, C., S. Hue, P. Kellam, and G. L. Smith. 2004. Poxvirus genomes: a phylogenetic analysis. J. Gen. Virol. 85:105-117.
24. Guo, Z. S., A. Naik, M. E. O'Malley, P. Popovic, R. Demarco, Y. Hu, X. Y. Yin, S. T. Yang, H. J. Zeh, B. Moss, M. T. Lotze, and D. L. Bartlett. 2005. The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2. Cancer Res. 65:9991-9998. (Pubitemid 41541480)
25. Haga, I. R., and A. G. Bowie. 2005. Evasion of innate immunity by vaccinia virus. Parasitology 130:S11-S25.
26. Harris, N., R. M. L. Buller, and G. Karupiah. 1995. Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J. Virol. 69:910-915.
27. Haspel, R. L., M. Salditt Georgieff, and J. E. Darnell. 1996. The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J. 15:6262-6268. (Pubitemid 26397899)
28. Hengel, H., C. Esslinger, J. Pool, E. Goulmy, and U. H. Koszinowski. 1995. Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J. Gen. Virol. 76:2987-2997. (Pubitemid 26003108)
29. Hengel, H., U. H. Koszinowski, and K. K. Conzelmann. 2005. Viruses know it all: new insights into IFN networks. Trends Immunol. 26:396-401.
30. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259:1742-1745.
31. Jacobs, N., R. A. J. Chen, C. Gubser, P. Najarro, and G. L. Smith. 2006. Intradermal immune response after infection with vaccinia virus. J. Gen. Virol. 87:1157-1161.
32. Karupiah, G., B. Coupar, I. Ramshaw, D. Boyle, R. Blanden, and M. Andrew. 1990. Vaccinia virus-mediated damage of murine ovaries and protection by virus-expressed interleukin-2. Immunol. Cell Biol. 68:325-333.
33. Karupiah, G., Q. W. Xie, R. M. L. Buller, C. Nathan, C. Duarte, and J. D. Macmicking. 1993. Inhibition of viral replication by interferon-gamma-induced nitric-oxide synthase. Science 261:1445-1448.
34. Kessler, D. S., D. E. Levy, and J. E. Darnell. 1988. Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes. Proc. Natl. Acad. Sci. USA 85:8521-8525.
35. Kohonencorish, M. R. J., N. J. C. King, C. E. Woodhams, and I. A. Ramshaw. 1990. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma. Eur. J. Immunol. 20:157-161. (Pubitemid 20087042)
36. Kotenko, S. V., G. Gallagher, V. V. Baurin, A. Lewis-Antes, M. L. Shen, N. K. Shah, J. A. Langer, F. Sheikh, H. Dickensheets, and R. P. Donnelly. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4:69-77. (Pubitemid 36109115)
37. Le, V. T., M. Trilling, M. Wilborn, H. Hengel, and A. Zimmermann. 2008. Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. J. Gen. Virol. 89:2416-2426.
38. Le, V. T., M. Trilling, A. Zimmermann, and H. Hengel. 2008. Mouse cytomegalovirus inhibits beta interferon (IFN-beta) gene expression and controls activation pathways of the IFN-beta enhanceosome. J. Gen. Virol. 89:1131-1141.
39. Legrand, F. A., P. H. Verardi, K. S. Chan, Y. Peng, L. A. Jones, and T. D. Yilma. 2005. Vaccinia viruses with a serpin gene deletion and expressing IFN-gamma induce potent immune responses without detectable replication in vivo. Proc. Natl. Acad. Sci. USA 102:2940-2945.
40. Liu, B., S. Mink, K. A. Wong, N. Stein, C. Getman, P. W. Dempsey, H. Wu, and K. Shuai. 2004. PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nat. Immunol. 5:891-898. (Pubitemid 39276233)
41. Liu, G., Q. Z. Zhai, D. J. Schaffner, A. G. Wu, A. Yohannes, T. M. Robinson, M. Maland, J. Wells, T. G. Voss, C. Bailey, and K. Alibek. 2004. Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma. FEMS Immunol. Med. Microbiol. 40:201-206. (Pubitemid 38368183)
42. Ludwig, H., Y. Suezer, Z. Waibler, U. Kalinke, B. S. Schnierle, and G. Sutter. 2006. Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara. J. Gen. Virol. 87:1145-1155.
43. Macmicking, J. D. 2004. IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol. 25:601-609. (Pubitemid 39369737)
44. Matsuyama, T., T. Kimura, M. Kitagawa, K. Pfeffer, T. Kawakami, N. Watanabe, T. M. Kundig, R. Amakawa, K. Kishihara, A. Wakeham, J. Potter, C. L. Furlonger, A. Narendran, H. Suzuki, P. S. Ohashi, C. J. Paige, T. Taniguchi, and T. W. Mak. 1993. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75:83-97.
45. McFadden, G. 2005. Poxvirus tropism. Nat. Rev. Microbiol. 3:201-213. (Pubitemid 40298220)
46. Meyer, T., A. Begitt, I. Lodige, M. van Rossum, and U. Vinkemeier. 2002. Constitutive and IFN-gamma-induced nuclear import of STAT1 proceed through independent pathways. EMBO J. 21:344-354. (Pubitemid 34137296)
47. Moss, B. 2007. Poxviridae: the viruses and their replication, p. 2905-2945. In D. Knipe and P. Howley (ed.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, PA.
48. Mossman, K., C. Upton, and G. McFadden. 1995. The myxoma virus-soluble interferon-gamma receptor homolog, M-T7, inhibits interferon-gamma in a species-specific manner. J. Biol. Chem. 270:3031-3038.
49. Muller, U., U. Steinhoff, L. F. L. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
50. Najarro, P., P. Traktman, and J. A. Lewis. 2001. Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation. J. Virol. 75:3185-3196.
51. Neubauer, H., A. Cumano, M. Muller, H. Wu, U. Huffstadt, and K. Pfeffer. 1998. Jak2 deficiency defines an essential developmental checkpoint in de- finitive hematopoiesis. Cell 93:397-409.
52. Paez, E., and M. Esteban. 1984. Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system. Virology 134:12-28.
53. Park, C., S. Li, E. Cha, and C. Schindler. 2000. Immune response in stat2 knockout mice. Immunity 13:795-804.
54. Pine, R., A. Canova, and C. Schindler. 1994. Tyrosine phosphorylated P91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN alpha and IFN gamma, and is likely to autoregulate the p91 gene. EMBO J. 13:158-167.
55. Ramana, C. V., M. P. Gil, Y. L. Han, R. M. Ransohoff, R. D. Schreiber, and G. R. Stark. 2001. Stat1-independent regulation of gene expression in response to IFN-gamma. Proc. Natl. Acad. Sci. USA 98:6674-6679.
56. Ramsauer, K., M. Farlik, G. Zupkovitz, C. Seiser, A. Kroger, H. Hauser, and T. Decker. 2007. Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-gamma-inducible gbp2 gene. Proc. Natl. Acad. Sci. USA 104:2849-2854.
57. Randall, R. E., and S. Goodbourn. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47.
58. Reif, D. M., B. A. McKinney, A. A. Motsinger, S. J. Chanock, K. M. Edwards, M. T. Rock, J. H. Moore, and J. E. Crowe. 2008. Genetic basis for adverse events after smallpox vaccination. J. Infect. Dis. 198:16-22.
59. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809. (Pubitemid 32979631)
60. Schmitz, F., A. Heit, S. Guggemoos, A. Krug, J. Mages, M. Schiemann, H. Adler, I. Drexler, T. Haas, R. Lang, and H. Wagner. 2007. Interferon-regulatory- factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Eur. J. Immunol. 37:315-327. (Pubitemid 46915571)
61. Shresta, S., K. L. Sharar, D. M. Prigozhin, H. M. Snider, P. R. Beatty, and E. Harris. 2005. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J. Immunol. 175:3946-3954. (Pubitemid 41292056)
62. Silverman, R. H. 2007. Viral encounters with 2′,5′- oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol. 81:12720-12729. (Pubitemid 350156909)
63. Smith, S. A., and G. J. Kotwal. 2002. Immune response to poxvirus infections in various animals. Crit. Rev. Microbiol. 28:149-185. (Pubitemid 35178638)
64. Stark, G. R., I. M. Kerr, B. R. G. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264. (Pubitemid 28411130)
65. Stockinger, S., T. Materna, D. Stoiber, L. Bayr, R. Steinborn, T. Kolbe, H. Unger, T. Chakraborty, D. E. Levy, M. Muller, and T. Decker. 2002. Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J. Immunol. 169:6522-6529. (Pubitemid 36903504)
66. Sutter, G., and B. Moss. 1992. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. USA 89:10847-10851.
67. Symons, J. A., A. Alcami, and G. L. Smith. 1995. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81:551-560.
68. Symons, J. A., D. C. Tscharke, N. Price, and G. L. Smith. 2002. A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence. J. Gen. Virol. 83:1953-1964.
69. Taniguchi, T., K. Ogasawara, A. Takaoka, and N. Tanaka. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623-655. (Pubitemid 32368048)
70. Terajima, M., and A. M. Leporati. 2005. Role of indoleamine 2,3-dioxygenase in antiviral activity of interferon-gamma against vaccinia virus. Viral Immunol. 18:722-729. (Pubitemid 43038536)
71. Thorne, S. H., D. L. Bartlett, and D. H. Kirn. 2005. The use of oncolytic vaccinia viruses in the treatment of cancer: a new role for an old ally? Curr. Gene Ther. 5:429-443.
72. Twardzik, D. R., J. P. Brown, J. E. Ranchalis, G. J. Todaro, and B. Moss. 1985. Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors. Proc. Natl. Acad. Sci. USA 82:5300-5304.
73. Verardi, P. H., L. A. Jones, F. H. Aziz, S. Ahmad, and T. D. Yilma. 2001. Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated in vivo without a concomitant reduction in immunogenicity. J. Virol. 75:11-18.
74. Wang, F., Y. Y. Ma, J. W. Barrett, X. J. Gao, J. Loh, E. Barton, H. W. Virgin, and G. McFadden. 2004. Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier. Nat. Immunol. 5:1266-1274. (Pubitemid 41057742)
75. Wang, Z., M. K. Choi, T. Ban, H. Yanai, H. Negishi, Y. Lu, T. Tamura, A. Takaoka, K. Nishikura, and T. Taniguchi. 2008. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc. Natl. Acad. Sci. USA 105:5477-5482.
76. Williamson, J. D., R. W. Reith, L. J. Jeffrey, J. R. Arrand, and M. Mackett. 1990. Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route. J. Gen. Virol. 71:2761-2767. (Pubitemid 20370524)
77. Wittek, R., M. Hanggi, and G. Hiller. 1984. Mapping of a gene coding for a major late structural polypeptide on the vaccinia virus genome. J. Virol. 49:371-378. (Pubitemid 14221307)
78. Xiang, Y., R. C. Condit, S. Vijaysri, B. Jacobs, B. R. G. Williams, and R. H. Silverman. 2002. Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus. J. Virol. 76:5251-5259. (Pubitemid 34441727)
79. Xu, R., A. J. Johnson, D. Liggitt, and M. J. Bevan. 2004. Cellular and humoral immunity against vaccinia virus infection of mice. J. Immunol. 172:6265-6271. (Pubitemid 38621233)
80. Yoshimura, A., T. Naka, and M. Kubo. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7:454-465.
81. Zhang, Z. N., M. R. Abrahams, L. A. Hunt, J. Suttles, W. Marshall, D. K. Lahiri, and G. J. Kotwal. 2005. The vaccinia virus N1L protein influences cytokine secretion in vitro after infection. Ann. N. Y. Acad. Sci. 1056:69-86. (Pubitemid 43030968)
82. Zhou, A. Q., Z. F. Chen, J. A. Rummage, H. Jiang, M. Kolosov, I. Kolosova, C. A. Stewart, and R. W. Leu. 1995. Exogenous interferon-gamma induces endogenous synthesis of interferon-alpha and interferon-beta by murine macrophages for induction of nitric-oxide synthase. J. Interferon Cytokine Res. 15:897-904.
83. Zimmermann, A., M. Trilling, M. Wagner, M. Wilborn, I. Bubic, S. Jonjic, U. Koszinowski, and H. Hengel. 2005. A cytomegaloviral protein reveals a dual role for STAT2 in IFN-gamma signaling and antiviral responses. J. Exp. Med. 201:1543-1553. (Pubitemid 40721000)